{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:50:25Z","timestamp":1747194625839,"version":"3.40.5"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Being expressed in all stages of B-cell development and having a significant value on the European Group for the Immunological Characterization of Acute Leukemias scoring system, CD79a is considered as an excellent pan-marker for lineage assignment of B cells by flow cytometry. Therefore, any lack or decrease in CD79a expression makes the diagnosis of B acute lymphoblastic leukemia cases very challenging, especially in developing country laboratories where flow cytometry analyses are not always available and, when they are, they are limited in the number of markers used for lineage assignment. Since this case is potentially interesting, we report a B acute lymphoblastic leukemia case with a lack of expression CD79a associated with intrachromosomal amplification of chromosome 21 genetic abnormality. We further discuss the practical challenges in the diagnosis of this case.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present the case of an 8-year-old Caucasian boy from eastern Morocco who was initially hospitalized for a hemorrhagic syndrome. Peripheral blood smear examination showed a significant number of blasts suggesting acute leukemia. Bone marrow was studied for morphology, cytochemistry, immunophenotyping, and cytogenetics. Flow cytometry analyses showed expression of CD19, CD22, CD10, CD34, and HLA-DR markers by leukemic blasts. The expression of CD79a, which was checked with two different monoclonal antibodies, confirms that this marker was severely decreased in this case. Cytogenetic study performed by fluorescence <jats:italic>in\u00a0situ<\/jats:italic> hybridization revealed the presence of intrachromosomal amplification of chromosome 21, a cytogenetic abnormality that is specific for B acute lymphoblastic leukemia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CD79a is one of the critical markers in the assignment of B acute lymphoblastic leukemia. In our case, we were lucky enough to be assisted by a few other markers of the B lineage that were positive in this case. Also, we mention the importance of proceeding to cytogenetic study, which in our case helped us to confirm the diagnosis made by flow cytometry by highlighting a cytogenetic abnormality that is specific to B acute lymphoblastic leukemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-03128-2","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:03:35Z","timestamp":1635375815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunophenotypic challenges in diagnosis of CD79a negativity in a patient with\u00a0B acute lymphoblastic leukemia harboring intrachromosomal amplification of chromosome 21: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0262-201X","authenticated-orcid":false,"given":"A.","family":"Berhili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bensalah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"ElMalki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Elyagoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Seddik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"issue":"2","key":"3128_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/00129039-200106000-00001","volume":"9","author":"PG Chu","year":"2001","unstructured":"Chu PG, Arber DA. CD79: a review. Appl Immunohistochem Mol Morphol. 2001;9(2):97\u2013106. https:\/\/doi.org\/10.1097\/00129039-200106000-00001.","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"3128_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1440-1827.2010.02634","volume":"61","author":"X Huang","year":"2011","unstructured":"Huang X, Takata K, Sato Y, et\u00a0al. Downregulation of the B-cell receptor signaling component CD79b in plasma cell myeloma: a possible post transcriptional regulation. Pathol Int. 2011;61(3):122\u20139. https:\/\/doi.org\/10.1111\/j.1440-1827.2010.02634.","journal-title":"Pathol Int"},{"issue":"4","key":"3128_CR3","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5732\/cjc.012.10041","volume":"32","author":"J-H Yu","year":"2013","unstructured":"Yu J-H, Dong J-T, Jia Y-Q, et\u00a0al. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients. Chin J Cancer. 2013;32(4):213\u201323. https:\/\/doi.org\/10.5732\/cjc.012.10041.","journal-title":"Chin J Cancer"},{"issue":"4","key":"3128_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1182\/blood.V86.4.1453.bloodjournal8641453","volume":"86","author":"DY Mason","year":"1995","unstructured":"Mason DY, Cordell JL, Brown MH, et\u00a0al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples. Blood. 1995;86(4):1453\u20139.","journal-title":"Blood"},{"issue":"1","key":"3128_CR5","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cancergencyto.2005.06.002","volume":"163","author":"I Kozlov","year":"2005","unstructured":"Kozlov I, Beason K, Yu C, Hughson M. CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity. Cancer Genet Cytogenet. 2005;163(1):62\u20137. https:\/\/doi.org\/10.1016\/j.cancergencyto.2005.06.002.","journal-title":"Cancer Genet Cytogenet"},{"issue":"10","key":"3128_CR6","first-page":"1783","volume":"9","author":"MC Bene","year":"1995","unstructured":"Bene MC, Castoldi G, Knapp W, et\u00a0al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995;9(10):1783\u20136.","journal-title":"Leukemia."},{"issue":"3","key":"3128_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cll.2007.05.005","volume":"27","author":"JA DiGiuseppe","year":"2007","unstructured":"DiGiuseppe JA. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy. Clin Lab Med. 2007;27(3):533\u201349. https:\/\/doi.org\/10.1016\/j.cll.2007.05.005.","journal-title":"Clin Lab Med"},{"key":"3128_CR8","doi-asserted-by":"publisher","unstructured":"Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. Longo DL, ed. N Engl J Med. 2015;373(16): 1541\u20131552. https:\/\/doi.org\/10.1056\/nejmra1400972.","DOI":"10.1056\/nejmra1400972"},{"key":"3128_CR9","doi-asserted-by":"publisher","DOI":"10.4084\/MJHID.2019.017","author":"N Gupta","year":"2019","unstructured":"Gupta N, Pawar R, Banerjee S, et\u00a0al. Spectrum and immunophenotypic profile of acute leukemia: a tertiary center flow cytometry experience. Mediter J Hematol Infect Dis. 2019. https:\/\/doi.org\/10.4084\/MJHID.2019.017.","journal-title":"Mediter J Hematol Infect Dis"},{"issue":"20","key":"3128_CR10","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, et\u00a0al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391\u2013405. https:\/\/doi.org\/10.1182\/blood-2016-03-643544.","journal-title":"Blood"},{"issue":"1","key":"3128_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/cyto.b.21518","volume":"94","author":"MN Dworzak","year":"2018","unstructured":"Dworzak MN, Buldini B, Gaipa G, et\u00a0al. AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia. Cytometry B Clin Cytom. 2018;94(1):82\u201393. https:\/\/doi.org\/10.1002\/cyto.b.21518.","journal-title":"Cytometry B Clin Cytom"},{"issue":"6","key":"3128_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1309\/391r-93yf-db4d-1l35","volume":"113","author":"R Lai","year":"2000","unstructured":"Lai R, Juco J, Lee SF, Nahirniak S, Etches WS. Flow cytometric detection of CD79a expression in T-cell acute lymphoblastic leukemias. Am J Clin Pathol. 2000;113(6):823\u201330. https:\/\/doi.org\/10.1309\/391r-93yf-db4d-1l35.","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"3128_CR13","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/leu.2012.120","volume":"26","author":"JJM van Dongen","year":"2012","unstructured":"van Dongen JJM, Lhermitte L, B\u00f6ttcher S, et\u00a0al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012;26(9):1908\u201375. https:\/\/doi.org\/10.1038\/leu.2012.120.","journal-title":"Leukemia"},{"issue":"10","key":"3128_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076115","volume":"8","author":"D Luger","year":"2013","unstructured":"Luger D, Yang Y-A, Raviv A, et\u00a0al. Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects. PLoS ONE. 2013;8(10): e76115. https:\/\/doi.org\/10.1371\/journal.pone.0076115.","journal-title":"PLoS ONE"},{"issue":"7","key":"3128_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/PAT.0b013e32834c726f","volume":"43","author":"W Bo","year":"2011","unstructured":"Bo W, Mei K, Zhaoming W, Hongtian Y, Yanfeng B, Xiaoying N. CD79a positive T cell lymphoma with bone marrow involvement. Pathology. 2011;43(7):737\u201340. https:\/\/doi.org\/10.1097\/PAT.0b013e32834c726f.","journal-title":"Pathology."},{"issue":"7","key":"3128_CR16","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.1182\/blood-2004-07-2630","volume":"105","author":"E Tiacci","year":"2005","unstructured":"Tiacci E, Orvietani P-L, Bigerna B, et\u00a0al. Tumor protein D52 (TPD52): a novel B-cell\/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VI. Blood. 2005;105(7):2812\u201320. https:\/\/doi.org\/10.1182\/blood-2004-07-2630.","journal-title":"Blood"},{"issue":"5","key":"3128_CR17","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5581\/1516-8484.20130111","volume":"35","author":"DRN Garcia","year":"2013","unstructured":"Garcia DRN, Arancibia AM, Ribeiro RC, Land MGP, Silva MLM. Intrachromosomal amplification of chromosome 21 (iAMP21) detected by ETV6\/RUNX1 FISH screening in childhood acute lymphoblastic leukemia: a case report. Rev Bras Hematol Hemoter. 2013;35(5):369\u201371. https:\/\/doi.org\/10.5581\/1516-8484.20130111.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"5","key":"3128_CR18","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1038\/leu.2013.317","volume":"28","author":"CJ Harrison","year":"2014","unstructured":"Harrison CJ, Moorman AV, Schwab C, et\u00a0al. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome. Leukemia. 2014;28(5):1015\u201321. https:\/\/doi.org\/10.1038\/leu.2013.317.","journal-title":"Leukemia"},{"issue":"27","key":"3128_CR19","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1200\/JCO.2013.49.1308","volume":"31","author":"NA Heerema","year":"2013","unstructured":"Heerema NA, Carroll AJ, Devidas M, et\u00a0al. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children\u2019s oncology group studies: a report from the children\u2019s oncology group. J Clin Oncol. 2013;31(27):3397\u2013402. https:\/\/doi.org\/10.1200\/JCO.2013.49.1308.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3128_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1309\/AJCPLUYF11HQBYRB","volume":"144","author":"RC Johnson","year":"2015","unstructured":"Johnson RC, Weinberg OK, Cascio MJ, et\u00a0al. Cytogenetic variation of B-lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 (iAMP21). Am J Clin Pathol. 2015;144(1):103\u201312. https:\/\/doi.org\/10.1309\/AJCPLUYF11HQBYRB.","journal-title":"Am J Clin Pathol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03128-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03128-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T23:04:45Z","timestamp":1635375885000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03128-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3128"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03128-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"28 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient's legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"531"}}